Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a novel metal-free amidation method via patent CN111039813B. Achieve cost reduction in pharmaceutical manufacturing with mild conditions and high yields.
Novel supramolecular method achieves >99.9% purity resveratrol by removing 3,4'-dihydroxystilbene. Green, scalable process for pharmaceutical intermediates.
Patent CN114349687B reveals metal-free asymmetric hydrogenation. Enhances safety and reduces costs for pharmaceutical intermediates manufacturing supply chains.
Novel chromium-free oxidation route for high-purity diacerein production ensuring cost efficiency and supply chain stability.
Patent CN113105329B details a palladium-free synthesis route for estrogen antagonist intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112979602B reveals a safer, scalable route for Baloxavir Marboxil intermediates, eliminating toxic selenium and cryogenic conditions for reliable supply.
Patent CN105820166A enables green photocatalytic synthesis of dihydrocarboline. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115490728A reveals a room-temperature synthesis of allyl phosphine derivatives using alkenyl carbonates, offering cost reduction and environmental benefits for fine chemical manufacturing.
Novel photo-copper catalysis method enables efficient delta-lactone synthesis with high enantioselectivity. This technology offers reliable supply chain solutions and cost reduction in pharmaceutical intermediate manufacturing for global partners.
Patent CN111116552B details a novel one-step synthesis of quinazolinones using vinyl heterocycles, offering high purity and scalable routes for pharmaceutical intermediate suppliers.
Novel metal-free electrocatalytic route for benzothiophene derivatives. High purity, room temperature, scalable process for API intermediates.
Patent CN102531983A reveals a safer, high-yield synthesis route for S-phenyl-4-toluenesulfonate, offering significant cost reduction and supply chain reliability for global manufacturers.
Advanced solid-phase peptide synthesis method reduces costs and improves supply chain reliability for high-purity Exenatide manufacturing globally.
Patent CN108586397A details a mild base-catalyzed route for tetronic acid. Achieve cost reduction in pharmaceutical intermediate manufacturing with high-purity outputs.
Patent CN111269193B reveals a green aqueous phosgenation route for benzo[e][1,3]oxazine-2,4-dione, offering high purity and significant cost reduction in API manufacturing.
Patent CN114685300A reveals a novel synthesis for o-chlorophenylglycine, eliminating red oil by-products and decolorization steps for superior cost efficiency and supply reliability.
Novel preparation method for Ozanimod intermediate offering high purity and scalable manufacturing solutions for pharmaceutical supply chains.
Novel three-step synthesis avoids palladium catalysts reducing cost and environmental impact for reliable API intermediate supply chains globally
Novel Entecavir preparation method enhances yield and purity. Reduces manufacturing complexity for reliable pharmaceutical intermediate supply chain stability.
Patent CN116041222B reveals safer midazolam synthesis. High purity, reduced steps, scalable for pharmaceutical intermediates supply chain efficiency.